Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel biomarkers for identifying progression of diabetic retinopathy

May 9, 2022

Gannex Pharma presents new FXR agonists

May 9, 2022

Discovery of GB-1101, selective oral HDAC6 inhibitor with potent antitumor activity in vivo

May 9, 2022

Taking aim at tumor metabolism, while taming toxicity

May 6, 2022

Clover reports neutralization findings from preclinical study of bivalent COVID-19 vaccine candidate

May 6, 2022

Preclinical pipeline progress at Intellia Therapeutics

May 6, 2022

Mosaic signs license agreement covering use of cowpea mosaic virus to treat cancer

May 6, 2022

Orion enters agreement with Jemincare for Nav1.8 blocker for treatment of pain

May 6, 2022

SPH-5030 demonstrates potent and selective activity in HER2-mutant cancer models

May 6, 2022

Betta Pharmaceuticals presents preclinical results for cancer candidates BPI-371153 and BPI-442096

May 6, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.